Variant report

Variant	rs6475603
Chromosome Location	chr9:22050612-22050613
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 21 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:16)

rs_ID	r²[population]
rs1333033	0.82[AFR][1000 genomes];0.91[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs1412831	1.00[AMR][1000 genomes]
rs1591137	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs3217979	0.90[AMR][1000 genomes]
rs3217989	0.80[AMR][1000 genomes]
rs57222759	0.90[AMR][1000 genomes]
rs58814679	1.00[AMR][1000 genomes]
rs60490000	0.90[AMR][1000 genomes]
rs7048912	1.00[AMR][1000 genomes]
rs73444375	0.90[AMR][1000 genomes]
rs73444381	0.90[AMR][1000 genomes]
rs73446312	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs73446314	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs73649993	1.00[EUR][1000 genomes]
rs73650043	1.00[EUR][1000 genomes]
rs7853953	0.80[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv529609	chr9:21708371-22537069	Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Bivalent/Poised TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
2	nsv8426	chr9:21763810-22176200	Weak transcription Strong transcription Active TSS Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	32 gene(s)	inside rSNPs	diseases
3	nsv1018514	chr9:21944275-22075326	Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Strong transcription Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
4	nsv892747	chr9:21984661-22068646	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Strong transcription Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
5	nsv531617	chr9:21985057-22809676	Genic enhancers Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	21 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:56 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:22042600-22052600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
2	chr9:22042800-22052600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
3	chr9:22045600-22051800	Weak transcription	Muscle Satellite Cultured Cells	--
4	chr9:22046600-22052600	Weak transcription	Sigmoid Colon	Sigmoid Colon
5	chr9:22047000-22051000	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
6	chr9:22049200-22050800	Genic enhancers	Dnd41	blood
7	chr9:22049200-22050800	Strong transcription	Hela-S3	cervix
8	chr9:22049200-22053800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
9	chr9:22049400-22053800	Enhancers	HUVEC	blood vessel
10	chr9:22049400-22054000	Enhancers	Cortex derived primary cultured neurospheres	brain
11	chr9:22049600-22052000	Enhancers	Primary B cells from cord blood	blood
12	chr9:22049600-22052200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
13	chr9:22049600-22052200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
14	chr9:22049600-22052200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
15	chr9:22049600-22052400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
16	chr9:22049800-22050800	Weak transcription	HUES64 Cell Line	embryonic stem cell
17	chr9:22049800-22051800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
18	chr9:22049800-22051800	Weak transcription	HMEC	breast
19	chr9:22049800-22051800	Weak transcription	HSMM	muscle
20	chr9:22049800-22052000	Enhancers	Primary hematopoietic stem cells	blood
21	chr9:22049800-22052000	Weak transcription	Osteobl	bone
22	chr9:22049800-22052200	Weak transcription	NHDF-Ad	bronchial
23	chr9:22050200-22050800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
24	chr9:22050200-22051000	Enhancers	Skeletal Muscle Female	skeletal muscle
25	chr9:22050200-22051400	Enhancers	Primary monocytes fromperipheralblood	blood
26	chr9:22050200-22051600	Enhancers	Primary neutrophils fromperipheralblood	blood
27	chr9:22050200-22051800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr9:22050200-22052000	Enhancers	Primary hematopoietic stem cells short term culture	blood
29	chr9:22050200-22052200	Enhancers	Primary B cells from peripheral blood	blood
30	chr9:22050200-22053400	Enhancers	Primary T helper cells fromperipheralblood	blood
31	chr9:22050200-22053800	Enhancers	NHEK	skin
32	chr9:22050400-22051000	Enhancers	Fetal Thymus	thymus
33	chr9:22050400-22051200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
34	chr9:22050400-22051200	Enhancers	Primary T cells from cord blood	blood
35	chr9:22050400-22051200	Genic enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr9:22050400-22051200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
37	chr9:22050400-22051600	Enhancers	Monocytes-CD14+_RO01746	blood
38	chr9:22050400-22051800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
39	chr9:22050400-22053200	Enhancers	Primary T helper naive cells from peripheral blood	blood
40	chr9:22050400-22053200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
41	chr9:22050400-22053200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
42	chr9:22050400-22053600	Enhancers	Primary T helper cells PMA-I stimulated	--
43	chr9:22050400-22053800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
44	chr9:22050600-22050800	Enhancers	Adipose Nuclei	Adipose
45	chr9:22050600-22050800	Weak transcription	NH-A	brain
46	chr9:22050600-22051000	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
47	chr9:22050600-22051000	Enhancers	Psoas Muscle	Psoas
48	chr9:22050600-22051200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
49	chr9:22050600-22051200	Enhancers	Primary T cells fromperipheralblood	blood
50	chr9:22050600-22051200	Enhancers	Esophagus	oesophagus

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links